COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring. |
University of Cambridge > Talks.cam > SciSoc – Cambridge University Scientific Society > Drug discovery: how Academia can Contribute
Drug discovery: how Academia can ContributeAdd to your list(s) Download to your calendar using vCal
If you have a question about this talk, please contact als60. Bringing together physics, chemistry and some biology, Sir Tom Blundell will be describing how his initiatives in drug discovery have moved to the Science Park in the early 2000s, but are now coming back to academia in order to work on new medicine for rare cancers and the diseases of third world poverty. Sir Prof Blundell graduated from Brasenose College Oxford, and has held several distinguished research positions at Oxford University, Birkbeck College, and the Imperial Cancer Research Fund Unit. He was Chief Execuitive of BBSRC from 1994-1996. Sir Prof Blundell has founded Astex, a highly successful company specialising in using computational techniques and X-ray crystallography to identify novel cancer drugs. All welcome; free for Scisoc members, £1 otherwise This talk is part of the SciSoc – Cambridge University Scientific Society series. This talk is included in these lists:
Note that ex-directory lists are not shown. |
Other listsCentre for Gender Studies-Public Events Pharmacology Tea Clubs Michaelmas 2014Other talksA transmissible RNA pathway in honeybees New approaches to old problems: controlling pathogenic protozoan parasites of poultry Adaptation in log-concave density estimation Around the world in 605 State energy agreements The Partition of India and Migration Market Socialism and Community Rating in Health Insurance Vision Journal Club: feedforward vs back in figure ground segmentation A Bourdiesian analysis of songwriting habitus |